Skip Ribbon Commands
Skip to main content
Home | Support RFF | Join E-mail List | Contact
RFF Logo
Skip navigation links
RESEARCH TOPICS
CENTERS
PUBLICATIONS
NEWS
EVENTS
RESEARCHERS
ABOUT RFF
 

 

 
Join E-mail List
Please provide your e-mail address to receive periodic newsletters and invitations to public events
 
 
Opportunities and Threats in Targeting Antimalarials for the AMFm: The Role of Diagnostics
Christopher J.M. Whitty, Heidi Hopkins, Evelyn Ansah, Toby Leslie, Hugh Reyburn
RFF Discussion Paper 08-41 | November 2008
RESEARCH TOPICS:
Abstract
In malaria-endemic countries, people commonly assume they have malaria when sick and treat themselves accordingly. The Affordable Medicines Facility-malaria (AMFm) will make effective drugs more available everywhere. If longstanding problems can be successfully addressed, the use of microscopy and rapid diagnostic tests (RDTs) for malaria diagnosis alongside AMFm (though not necessarily directly part of it) could improve the management of both malaria and other febrile illness, as well as the cost-effectiveness of AMFm. In peripheral areas, RDTs are the only practical option, but available RDTs have limitations: all-or-none test results, variable heat stability, an inability to diagnose non-falciparum malaria and safety risks (especially HIV and hepatitis B) related to blood sampling. Of equal concern is that negative test results—meaning no malaria—are often ignored and patients treated anyway. R&D to solve technical problems and operational research on better ways to deploy RDTs and to make diagnosis count are needed.
RELATED SUBTOPICS
Africa
RFF Home | RFF Press: An Imprint of Routledge Terms of Use | Privacy Policy | Copyright Notice
1616 P St. NW, Washington, DC 20036 · 202.328.5000 Feedback | Contact Us